Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Learn about the types of providers who treat patients with age-related cognitive decline and dementia and how to get the most out of your initial visit.

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

A milestone review examining 1.4 million patients worldwide found that those who do not see the same doctor regularly are ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

The 2025 list awards a Companion of Honour, of which there are only 65 recipients at any time, to author and screenwriter Sir ...

Researchers found that combining cardiovascular disease drug classes, particularly antihypertensives, can reduce risk of dementia.